Scientist Solutions: International Life Science Community By Scientists For Scientists

Thanks to our sponsors who make this site possible

    

Scientist-Solutions

 



Google+

At Scientist Solutions we cherish our role as a trusted source of information for scientists.  We hope that our newly designed site will make it easier than ever for you to access everything we have to offer.   Things may have moved around a little, but rest assured that all the features you enjoyed on our old site (the forums, the protocols, the events, my bench space, blogs)  are still here.  

Our Discussion Forums

Scientist Solutions began as a discussion board for life scientists and that is still one of our core offerings.   If you are looking for the discussion forums, please click "The Forums"  from the navigation bar above or click here.

Protocols and SciEvents

Always on the look out for new ways to help scientists to help each other,  Scientist Solutions introduced a new protocols section and an events section to our site in the past year.   Both have been very popular.   If you haven't yet discovered these listings, we invite you to do so now. 

Our Protocol Finder provides an easily searchable database of protocols that you can use both to find a protocol you need or to share the protocols that you rely on.  Just click "Protocol Finder" from the navigation bar above, or click here.

Our SciEvents section is setting out to be the most comprehensive listing of conferences, seminars, classes and webinars for life scientists on the web.   Search events listings by date, topic or type of event.    You are most welcome to add your own events to our listing too.   Just click SciEvents from the navigation bar above, or click here.

My Bench SpaceMembership Management

Are you looking for how to log in or wondering what happened to your bench space?     On our new site, we have made it much easier for you to manage your account and profile.   After logging in (note that the log in area has moved down the page),  you will see your new member status panel on the right hand side of the home page and every page.    Look here for an overview of your member information and find easy access to your newly remodeled My Bench Space, where you'll be able to edit your account information and preferences and manage your public profile.   Just click "Go to My Bench Space" from your member status panel or click here.

Blogging

Notice that featured blogs are now presented on the home page just below this article.   To read all blogs, just click the "view more" link below the featured blogs.   To create your own blog, go to your My Bench Space pages and click on the "blogs" tab.  To get to My Bench Space, log in then click the "Go to My Bench Space" link in your member status panel (see above) or just click here

Give us your feedback

We understand that it takes a little adjustment time to get used to a new design.  We apologize for any temporary confusion, but hope that once you've familiarized yourself with the new design and features you will be very pleased.   Either way, we would love to hear what you think.  Please share your opinion by clicking the 'contact us'  link at the top right of any page and send us a note or click here.




Latest Member Blogs

Member
Total Posts: 1
9/13/2016
02:55AM
Member
Total Posts: 1
12/18/2015
02:17PM
Member
Total Posts: 1
12/6/2015
02:00PM




Science News Feeds

Click a source to select it and see feeds below

BioScience News
Pharmaceutical News
Biotechnology News
Today's Science News
This Week in Science
Science (Editorial)
Science Now
Nextwave
New York Times
BBC
Bioscreening
Journals
Journal of Biology
Nature
European Journal of Cell Biology
Virology Journal
Science
PNAS
Magazines
New Scientist
The Scientist
Pharmaceutical Business Review
Life Sciences World
Science News

Biotechnology - Google News
Google News
ImmunoGen's (IMGN) "Buy" Rating Reiterated at Jefferies Group LLC - Community Financial News

ImmunoGen's (IMGN) "Buy" Rating Reiterated at Jefferies Group LLC
Community Financial News
They currently have a $6.00 price target on the biotechnology company's stock. A number of other research analysts have also recently commented on IMGN. Canaccord Genuity set a $6.00 target price on ImmunoGen and gave the company a buy rating in a ...

and more »
Analysts Set BIO-TECHNE Corp (TECH) PT at $117.00 - Sports Perspectives

Analysts Set BIO-TECHNE Corp (TECH) PT at $117.00
Sports Perspectives
The biotechnology company reported $0.81 EPS for the quarter, missing analysts' consensus estimates of $0.85 by $0.04. The firm earned $131.80 million during the quarter, compared to analysts' expectations of $134.74 million. BIO-TECHNE Corp had a ...

and more »
Pacific Biosciences of California (PACB) Announces Earnings Results, Misses Estimates By $0.03 EPS - Sports Perspectives

Sports Perspectives

Pacific Biosciences of California (PACB) Announces Earnings Results, Misses Estimates By $0.03 EPS
Sports Perspectives
Pacific Biosciences of California logo Pacific Biosciences of California (NASDAQ:PACB) issued its quarterly earnings results on Wednesday. The biotechnology company reported ($0.26) earnings per share (EPS) for the quarter, missing analysts' consensus ...

and more »
Jefferies Group LLC Reiterates Sell Rating for United Therapeutics Co. (UTHR) - Sports Perspectives

Jefferies Group LLC Reiterates Sell Rating for United Therapeutics Co. (UTHR)
Sports Perspectives
They currently have a $116.00 price target on the biotechnology company's stock. Jefferies Group LLC's price target points to a potential downside of 7.72% from the stock's previous close. Several other research firms have also recently commented on UTHR.

and more »
United Therapeutics Co. (UTHR) Given a $125.00 Price Target by JPMorgan Chase & Co. Analysts - Chaffey Breeze

United Therapeutics Co. (UTHR) Given a $125.00 Price Target by JPMorgan Chase & Co. Analysts
Chaffey Breeze
The brokerage currently has a “hold” rating on the biotechnology company's stock. JPMorgan Chase & Co.'s target price would suggest a potential downside of 0.56% from the company's previous close. Several other analysts also recently commented on the ...

and more »
Opko Health Inc. (OPK) Stake Raised by Dimensional Fund Advisors LP - Sports Perspectives

Sports Perspectives

Opko Health Inc. (OPK) Stake Raised by Dimensional Fund Advisors LP
Sports Perspectives
The firm owned 1,589,903 shares of the biotechnology company's stock after buying an additional 30,851 shares during the period. Dimensional Fund Advisors LP owned about 0.29% of Opko Health worth $14,811,000 at the end of the most recent quarter.

and more »
Corcept Therapeutics Incorporated (CORT) Shares Sold by Metropolitan Life Insurance Co. NY - The Cerbat Gem

Corcept Therapeutics Incorporated (CORT) Shares Sold by Metropolitan Life Insurance Co. NY
The Cerbat Gem
The fund owned 53,311 shares of the biotechnology company's stock after selling 3,933 shares during the period. Metropolitan Life Insurance Co. NY's holdings in Corcept Therapeutics were worth $387,000 at the end of the most recent quarter. Other hedge ...

and more »
Edge Therapeutics Inc (EDGE) Stake Maintained by Fmr LLC - Markets Daily

Edge Therapeutics Inc (EDGE) Stake Maintained by Fmr LLC
Markets Daily
FMR LLC maintained its stake in Edge Therapeutics Inc (NASDAQ:EDGE) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 209,078 shares of the biotechnology company's stock at ...

and more »
Dimensional Fund Advisors LP Acquires 7130 Shares of BioMarin Pharmaceutical Inc. (BMRN) - The Cerbat Gem

Dimensional Fund Advisors LP Acquires 7130 Shares of BioMarin Pharmaceutical Inc. (BMRN)
The Cerbat Gem
The firm owned 180,646 shares of the biotechnology company's stock after buying an additional 7,130 shares during the period. Dimensional Fund Advisors LP owned approximately 0.11% of BioMarin Pharmaceutical worth $14,966,000 at the end of the ...

and more »
Albany Molecular Research, Inc. (AMRI) Stake Maintained by State Board of Administration of Florida Retirement System - The Cerbat Gem

Albany Molecular Research, Inc. (AMRI) Stake Maintained by State Board of Administration of Florida Retirement System
The Cerbat Gem
The fund owned 12,318 shares of the biotechnology company's stock at the end of the fourth quarter. State Board of Administration of Florida Retirement System's holdings in Albany Molecular Research were worth $231,000 at the end of the most recent ...

and more »